G. Ardine de Wit
G. Ardine de Wit
University Medical Centre Utrecht & National Institute of Public Health, the Netherlands
Geverifieerd e-mailadres voor rivm.nl
Titel
Geciteerd door
Geciteerd door
Jaar
Lifetime medical costs of obesity: prevention no cure for increasing health expenditure
PHM Van Baal, JJ Polder, GA de Wit, RT Hoogenveen, TL Feenstra, ...
PLoS Med 5 (2), e29, 2008
2972008
Dutch tariff for the five-level version of EQ-5D
MM Versteegh, KM Vermeulen, SMAA Evers, GA De Wit, R Prenger, ...
Value in health 19 (4), 343-352, 2016
2912016
Sensitivity and perspective in the valuation of health status: whose values count?
GA De Wit, JJV Busschbach, FT De Charro
Health economics 9 (2), 109-126, 2000
2532000
Economic evaluation of end stage renal disease treatment
GA De Wit, PG Ramsteijn, FT de Charro
Health policy 44 (3), 215-232, 1998
2241998
Age-specific incidence and prevalence of keratoconus: a nationwide registration study
DA Godefrooij, GA De Wit, CS Uiterwaal, SM Imhof, RPL Wisse
American journal of ophthalmology 175, 169-172, 2017
1652017
The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination
H de Melker, G Berbers, S Hahné, H Rümke, S van den Hof, A de Wit, ...
Vaccine 24 (18), 3946-3952, 2006
1582006
Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective
IK Veldhuijzen, M Toy, SJM Hahné, GA De Wit, SW Schalm, A Robert, ...
Gastroenterology 138 (2), 522-530, 2010
1552010
Effectiveness and Efficiency of Controlling Campylobacter on Broiler Chicken Meat
AH Havelaar, MJJ Mangen, AA De Koeijer, MJ Bogaardt, EG Evers, ...
Risk Analysis: An International Journal 27 (4), 831-844, 2007
1472007
Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis
JP Greving, FLJ Visseren, GA De Wit, A Algra
Bmj 342, 2011
1342011
Economic evaluation of vaccination programmes
P Beutels, WJ Edmunds, F Antoñanzas, GA De Wit, D Evans, R Feilden, ...
Pharmacoeconomics 20 (1), 1-7, 2002
1082002
Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation
IVF van den Broek, JEAM van Bergen, EEHG Brouwers, JSA Fennema, ...
Bmj 345, e4316, 2012
1052012
Rapid screening of methicillin‐resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects
MWM Wassenberg, JAJW Kluytmans, ATA Box, RW Bosboom, ...
Clinical microbiology and infection 16 (12), 1754-1761, 2010
1042010
Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment
RW Sprengers, M Teraa, FL Moll, GA de Wit, Y van der Graaf, MC Verhaar
Journal of Vascular Surgery 52 (4), 843-849. e1, 2010
982010
Costs of gastroenteritis in The Netherlands
WE Van Den Brandhof, GA De Wit, MAS De Wit, Y Van Duynhoven
Epidemiology & Infection 132 (2), 211-221, 2004
962004
Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
MJJ Mangen, MH Rozenbaum, SM Huijts, CH van Werkhoven, ...
European Respiratory Journal 46 (5), 1407-1416, 2015
932015
Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157
AH Havelaar, Y Van Duynhoven, MJ Nauta, M Bouwknegt, AE Heuvelink, ...
Epidemiology & Infection 132 (3), 467-484, 2004
932004
A comparison of quality of life of patients on automated and continuous ambulatory peritoneal dialysis
GA De Wit, MP Merkus, RT Krediet, FT De Charro
Peritoneal Dialysis International 21 (3), 306-312, 2001
862001
Preventive exercises reduced injury-related costs among adult male amateur soccer players: a cluster-randomised trial
MR Krist, AMC van Beijsterveldt, FJG Backx, GA de Wit
Journal of physiotherapy 59 (1), 15-23, 2013
842013
The effect of including an opt-out option in discrete choice experiments
J Veldwijk, MS Lambooij, EW de Bekker-Grob, HA Smit, GA de Wit
PloS one 9 (11), e111805, 2014
792014
Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity
PHM Van Baal, RT Hoogenveen, AG de Wit, HC Boshuizen
Population Health Metrics 4 (1), 14, 2006
752006
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20